B. Riley Reaffirms “Neutral” Rating for Longboard Pharmaceuticals (NASDAQ:LBPH)
B. Riley reaffirmed their neutral rating on shares of Longboard Pharmaceuticals (NASDAQ:LBPH – Free Report) in a research report report published on Monday morning, MarketBeat Ratings reports. They currently have a $60.00 price target on the stock, up from their prior price target of $45.00. A number of other research analysts have also recently issued […]
More Stories
SOLVE Price Up 1.9% Over Last Week (SOLVE)
SOLVE (SOLVE) traded 1.5% lower against the U.S. dollar during the one day period ending at 8:00 AM E.T. on...
Moon Tropica (CAH) Price Reaches $11.93 on Top Exchanges
Moon Tropica (CAH) traded down 0.4% against the US dollar during the 1-day period ending at 8:00 AM E.T. on...
Wojak Finance (WOJ) Hits Self Reported Market Cap of $4.24 Million
Wojak Finance (WOJ) traded down 1.6% against the U.S. dollar during the 1-day period ending at 8:00 AM Eastern on...
Symbol (XYM) Trading 3.9% Lower Over Last Week
Symbol (XYM) traded 0.2% lower against the US dollar during the 24-hour period ending at 8:00 AM E.T. on October...
NetMind Token (NMT) Hits Self Reported Market Cap of $94.81 Million
NetMind Token (NMT) traded down 6.5% against the dollar during the twenty-four hour period ending at 8:00 AM Eastern on...
Performance Food Group (NYSE:PFGC) Sets New 12-Month High – Time to Buy?
Performance Food Group (NYSE:PFGC – Get Free Report)’s share price reached a new 52-week high on Tuesday . The company...